| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |